Loading...

Joel Baumgartner

Title(s)Assistant Clinical Professor, Surgery
SchoolHealth Sciences
Address9500 Gilman Drive #0987
La Jolla CA 92093
Phone858-246-0581
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Joel M. Baumgartner, MD is a surgical oncologist with expertise in cancers of the GI tract and melanoma. He is board certified in general surgery and completed a surgical oncology fellowship at the University of Pittsburgh with a focus on clinical research, which included additional training in the development and conduct of clinical trials.

    Dr. Baumgartner has specific expertise and interest in treating tumors that have metastasized to the abdomen, using a promising treatment known as the “chemo bath" or hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). This treatment involves surgical resection of all tumors followed by circulation of heated chemotherapy throughout the abdomen. This technique avoids many of the toxicities associated with systemic chemotherapy, while exposing the abdomen to higher concentrations of chemotherapy. Dr. Baumgartner spent two years working and training at one of highest volume HIPEC centers in the world at the University of Pittsburgh and therefore has significant experience with this procedure.

    Dr. Baumgartner also treats melanoma and performs wide local excision of these tumors, sentinel lymph node biopsies and lymph node dissections.

    Dr. Baumgartner is a member of numerous societies including the Society of Surgical Oncology, the American Society of Clinical Oncology and is an associate member of the American Association for Cancer Research and the American College of Surgeons. His research interests are in clinical trials, HIPEC, melanoma and immunotherapy.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study. Ann Surg Oncol. 2020 Apr 21. Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP. PMID: 32318945.
      View in: PubMed   Mentions:    Fields:    
    2. ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases. Ann Surg Oncol. 2020 Apr 17. Baumgartner JM, Riviere P, Kurzrock R. PMID: 32303875.
      View in: PubMed   Mentions:    Fields:    
    3. Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. J Clin Med. 2020 Mar 10; 9(3). Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM. PMID: 32164300.
      View in: PubMed   Mentions:
    4. Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg. 2020 Jan; 24(1):165-176. Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH. PMID: 31745888.
      View in: PubMed   Mentions:    Fields:    
    5. Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol. 2020 Mar; 27(3):783-792. Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM. PMID: 31659645.
      View in: PubMed   Mentions:    Fields:    
    6. ASO Author Reflections: Venous Thromboembolism after CRS/HIPEC. Ann Surg Oncol. 2019 12; 26(Suppl 3):758-759. Baumgartner JM, Khan S. PMID: 31576472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020 03; 219(3):478-483. Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM. PMID: 31558307.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg. 2020 Jan; 24(1):155-164. Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. PMID: 31428960.
      View in: PubMed   Mentions:    Fields:    
    9. Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3611-3617. Baumgartner JM, Marmor R, Hsu A, Veerapong J, Kelly KJ, Lowy AM. PMID: 31190209.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2019 Jul; 26(7):2276-2284. Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM. PMID: 31065960.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    11. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Ann Surg Oncol. 2019 Jul; 26(7):2234-2240. Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ. PMID: 31016486.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? Ann Surg Oncol. 2019 May; 26(5):1421-1427. Kelly KJ, Alsayadnasser M, Vaida F, Veerapong J, Baumgartner JM, Patel S, Ahmad S, Barone R, Lowy AM. PMID: 30815802.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis. Ann Surg Oncol. 2018 12; 25(Suppl 3):772-773. Baumgartner JM, Kurzrock R. PMID: 30421042.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. ASO Author Reflections: Recurrence Predictors in Mucinous Appendiceal Tumors. Ann Surg Oncol. 2018 12; 25(Suppl 3):763-764. Baumgartner JM. PMID: 30411269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. Clin Cancer Res. 2018 12 15; 24(24):6248-6256. Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R. PMID: 30348637.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma. J Gastrointest Surg. 2019 04; 23(4):879-881. de la Torre J, Banerjee S, Baumgartner J, Lin GY, Burgoyne AM, Kirane A, Sicklick J. PMID: 30132292.
      View in: PubMed   Mentions:    Fields:    
    17. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. Ann Surg Oncol. 2018 Aug; 25(8):2400-2408. Baumgartner JM, Raymond VM, Lanman RB, Tran L, Kelly KJ, Lowy AM, Kurzrock R. PMID: 29948422.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. The Use of Solicited Publishing by Academic Surgeons. Surgery. 2018 08; 164(2):212-218. Nguyen V, Marmor RA, Ramamoorthy SL, Costantini TW, Baumgartner JM, Berumen J, Jacobsen GR, Sicklick JK. PMID: 29724409.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients. World J Surg Oncol. 2018 Apr 26; 16(1):87. Weiss A, Ward EP, Baumgartner JM, Lowy AM, Kelly KJ. PMID: 29699564.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. Ann Surg Oncol. 2018 May; 25(5):1184-1192. Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner JM, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S. PMID: 29484565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC. Ann Surg Oncol. 2018 Mar; 25(3):702-708. Reghunathan M, Kelly KJ, Valasek MA, Lowy AM, Baumgartner JM. PMID: 29282599.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    22. The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA. Mol Cancer Ther. 2018 01; 17(1):297-305. Riviere P, Fanta PT, Ikeda S, Baumgartner J, Heestand GM, Kurzrock R. PMID: 29133621.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    23. Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):91-97. Kelly KJ, Cajas L, Baumgartner JM, Lowy AM. PMID: 29090402.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery. J Surg Res. 2018 01; 221:183-189. Baumgartner JM, McKenzie S, Block S, Costantini TW, Lowy AM. PMID: 29229126.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care. PLoS One. 2017; 12(6):e0179216. Valasek MA, Thung I, Gollapalle E, Hodkoff AA, Kelly KJ, Baumgartner JM, Vavinskaya V, Lin GY, Tipps AP, Hosseini MV, Lowy AM. PMID: 28591173.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw. 2016 11; 14(11):1357-1370. VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A. PMID: 27799507.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. Case Rep Obstet Gynecol. 2016; 2016:6841989. Vavinskaya V, Baumgartner JM, Ko A, Saenz CC, Valasek MA. PMID: 27843660.
      View in: PubMed   Mentions:
    28. Are self-identified "disadvantaged" students less likely to enter surgical residencies? A single-institution study. J Surg Res. 2016 05 15; 202(2):253-8. Unkart JT, Reid CM, Baumgartner JM, Wallace AM, Kelly CJ. PMID: 27229098.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2016 May; 23(5):1609-17. Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. PMID: 26678406.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    30. Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery. Ann Surg Oncol. 2016 May; 23(5):1461-7. Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM. PMID: 26542584.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    31. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. 2015 Sep 01; 121(17):2960-7. Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. PMID: 25930983.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    32. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei. Ann Surg Oncol. 2015 May; 22(5):1722-5. Kelly KJ, Baumgartner JM, Lowy AM. PMID: 25395145.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    33. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1716-21. Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. PMID: 25145504.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    34. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014 Dec; 110(7):779-85. Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R. PMID: 25088304.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    35. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol. 2014 Dec; 21(13):4195-201. Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. PMID: 24854493.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis. JAMA Surg. 2014 Mar; 149(3):237-43. Tran Cao HS, Lopez N, Chang DC, Lowy AM, Bouvet M, Baumgartner JM, Talamini MA, Sicklick JK. PMID: 24402232.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol. 2013 Mar; 107(4):329-34. Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA. PMID: 23386388.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg. 2012 Jun; 16(6):1152-9. Baumgartner JM, Krasinskas A, Daouadi M, Zureikat A, Marsh W, Lee K, Bartlett D, Moser AJ, Zeh HJ. PMID: 22399269.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    39. DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors. J Surg Res. 2012 Jul; 176(1):301-8. Baumgartner JM, Jordan KR, Hu LJ, Wilson CC, Banerjee A, McCarter MD. PMID: 21962733.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    40. Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res. 2009 Jun; 29(6):333-8. Baumgartner JM, Nydam TL, Clarke JH, Banerjee A, Silliman CC, McCarter MD. PMID: 19441884.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    41. Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery. Surgery. 2009 Apr; 145(4):345-50. Baumgartner JM, McCarter MD. PMID: 19303982.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    42. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg. 2009 Jan; 208(1):110-9. Baumgartner JM, Silliman CC, Moore EE, Banerjee A, McCarter MD. PMID: 19228512.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    43. Increased survival from stage IV melanoma associated with fewer regulatory T Cells. J Surg Res. 2009 Jun 01; 154(1):13-20. Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD. PMID: 19062042.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    Joel's Networks
    Concepts (178)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (35)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑